Viewing Study NCT03201458


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-01-10 @ 6:30 PM
Study NCT ID: NCT03201458
Status: COMPLETED
Last Update Posted: 2024-04-05
First Post: 2017-06-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-08
Start Date Type: ACTUAL
Primary Completion Date: 2020-08-07
Primary Completion Date Type: ACTUAL
Completion Date: 2024-02-19
Completion Date Type: ACTUAL
First Submit Date: 2017-06-27
First Submit QC Date: None
Study First Post Date: 2017-06-28
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-05-11
Results First Submit QC Date: None
Results First Post Date: 2023-07-11
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-07
Last Update Post Date: 2024-04-05
Last Update Post Date Type: ACTUAL